Since late September 2017, Ruthenium 106 has been detected by several European networks involved in the monitoring of atmospheric radioactive contamination. Ruthenium 106 is a radionuclide of artificial origin. It is a fission product from the nuclear industry. This radionuclide is also used in the medical field for brachytherapy treatments.

The very low levels of atmospheric contamination of Ruthenium 106 observed to date by European monitoring networks have no environmental or health consequences in monitored countries. Nevertheless, all European networks maintain a watchful vigilance on this presence of ruthenium in the air.

For further details, you can find information on the websites of our NERIS supporting organisations:

Next events

  • IRPA 15, Seoul, on site : 18-22 January, on-line : 18 January - 5 February 2021
  • NERIS Workshop, 9-11 June 2021
  • RICOMET 2021, 29 June-1st July 2021
  • RP Week 2021, Estoril, 27 September-1st October 2021 (to be confirmed)

Contact Us.

 

+33 1 55 52 19 20

 
 

NERIS - ℅ CEPN
28 rue de la Redoute
92260 Fontenay-aux-Roses
France

 
 

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Login Form